glp-1 migraine receptor agonists may have a role in chronic migraine, with a large real-world analysis showing lower healthcare utilization and less need for additional medications over 1 year compared with topiramate. “ New Findings Suggest GLP-1s May

Injections take seconds, with rotating injection sites on the thigh, abdomen, or upper arm

For us, GLP-1s, last year, were number 32, and this year theyre number one [in pharmacy spending]. Human Resources Director, health benefits administrator Before we knew it, we spent half a million dollars and were projected to go up to $1.2 million the following year. Manager of Compensation and Benefits Administration, large retail firm Ill just say our GLP-1 agonist spending year over year was increasing 50% for weight loss

18 :e10e13

However, results vary, and it's important to discuss expectations with a healthcare provider

However, Wegovy continues to receive coverage for two specific FDA-approved indications beyond general weight management